drugset / Trial / NCT00407680

Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension

NCT00407680

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To observe the effect of intensive medical treatment for type 2 diabetic patients with hypertension: to discover whether or not intensive medical treatment improves proteinuria, and the difference between the clinical meaning of responder and non-responder (criteria: 50% reduced proteinuria continuing 6 months or more during the observation period.)

Timeline

Start
2006-10
Primary completion
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluvastatin Other / unclassified
Subject Valsartan Small molecule